However, at this time, we continue to believe that it is important that the elements of the particular add-on service are documented in the medical record, though we may consider this comment in future rulemaking
Peptide therapy should only be considered through licensed medical evaluation and appropriate pharmacy channels
The commenter further stated that if CMS finalizes this proposed policy, CMS should provide greater transparency on the inclusion of DCAPS in the Part B inflation rebate requirements, but the commenter did not elaborate or provide an example
This might include modifying doses, changing administration timing, or adding complementary treatments
Always consult a healthcare provider for personalized recommendations.
It depends on the concentration after mixing